Testing on Humans: Predict Hepatotoxicity and Drug Clearance Ahead of Clinical Trials Using OOC
CN Bio Webinar Series 2 - 2020
Current in vitro approaches for investigational toxicology, drug metabolism (DMPK) and safety are limited and are not fully representative of human response; therefore, drugs showing acceptable preclinical toxicity often fail in human clinical trials, and accurately predicting human drug exposure for new compounds is challenging and costly.
Microphysiological Systems (MPS), or Organ-on-chip (OOC) technologies are a trending way to bridge the gap between traditional DMPK/toxicology assays and human trials by providing more robust and reliable data that translate into clinical outcomes.
CN Bio offers preclinical investigational toxicology and DMPK services using its proprietary, industry-proven PhysioMimix™ OOC technology and liver-on-a-chip model. In this webinar, we will share our latest advances in investigational toxicology, drug clearance and drug safety, highlighting how the translatable, human-relevant data generated using CN Bio’s liver-on-a-chip model can be used to support (or call into question) the conclusions of internal pre-clinical studies, helping you to make data driven decisions with greater confidence.
Watch this webinar to learn about:
Developing liver-on-chip MPS systems and comparison to traditional in vitro liver approaches
Modeling human hepatotoxicity prediction using liver-MPS
Modeling human drug clearance using liver-MPS
Data validating and translatability between organ-on-chips and human
Accessing CN Bio MPS technology
Видео Testing on Humans: Predict Hepatotoxicity and Drug Clearance Ahead of Clinical Trials Using OOC канала CN Bio
Current in vitro approaches for investigational toxicology, drug metabolism (DMPK) and safety are limited and are not fully representative of human response; therefore, drugs showing acceptable preclinical toxicity often fail in human clinical trials, and accurately predicting human drug exposure for new compounds is challenging and costly.
Microphysiological Systems (MPS), or Organ-on-chip (OOC) technologies are a trending way to bridge the gap between traditional DMPK/toxicology assays and human trials by providing more robust and reliable data that translate into clinical outcomes.
CN Bio offers preclinical investigational toxicology and DMPK services using its proprietary, industry-proven PhysioMimix™ OOC technology and liver-on-a-chip model. In this webinar, we will share our latest advances in investigational toxicology, drug clearance and drug safety, highlighting how the translatable, human-relevant data generated using CN Bio’s liver-on-a-chip model can be used to support (or call into question) the conclusions of internal pre-clinical studies, helping you to make data driven decisions with greater confidence.
Watch this webinar to learn about:
Developing liver-on-chip MPS systems and comparison to traditional in vitro liver approaches
Modeling human hepatotoxicity prediction using liver-MPS
Modeling human drug clearance using liver-MPS
Data validating and translatability between organ-on-chips and human
Accessing CN Bio MPS technology
Видео Testing on Humans: Predict Hepatotoxicity and Drug Clearance Ahead of Clinical Trials Using OOC канала CN Bio
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Organ-on-Chip Studies with Physiomimix OOC from CNBio (60 second walkthrough)
ALL STEPS
CN BIO
WEBINAR: Organ on a Chip: Improving Preclinical Studies for Faster Drug Development
Benchtop Organ-on-Chip Device: Physiomimix from CNBio (60 second walkthrough)
Organ-on-Chip Studies Workflow Walk-Through (1/6): PhysioMimix T1 from CN Bio
Engineering Mucosal Barriers: From Organoids to Organs-on-Chips
Organ-on-Chip Studies Workflow (3/6) Dosing with PhysioMimix T1 from CN Bio
PhysioMimix™ OOC - Single and multi organ-on-a-chip systems
Introducing the benefits of a human-relevant organ-on-a-chip approach to drug discovery - CN Bio.
We are CN Bio - About Us
Introducing our NEW PhysioMimix HT (Higher Throughput)
Predicting the future: humanised drug evaluation testing using organ-on-a-chip technology
Organ-on-Chip Studies Workflow (5/6) Multi-Organ Analysis with PhysioMimix T1 from CN Bio
The Rhythm of Life: Using Microfluidics to Mimic Blood Flow. Single and Multi-Organ-on-a-Chip Models
5 Minute Guide to Human Organ-on-Chip Studies: Cells, Tissues, Organs and Multi-Organ Experiments
How our PhysioMimix system (Organ-on-a-Chip) works
Organ-on-Chip Studies Workflow (5/6) Multi-Organ Analysis with PhysioMimix OOC from CN Bio
Go with the Flow: Application of Microfluidic 3D Liver Chip Models for Genotoxity Testing
Organ-on-Chip Studies Workflow (2/6) Cell Culture with PhysioMimix T1 from CN Bio